Dishman Pharma likely to get $40 mn from Abbott & Merck
According to sources, the company officials met Abbott & Merck last week. Abbott & Merck are expected to come for plant inspection next month.
By ET Bureau |
MUMBAI: Shares of Dishman Pharma ended lower on Wednesday even as ET Now reported that the company is likely to get new orders worth $40 million from Abbott & Merck.
According to sources, the company officials met Abbott & Merck last week. Abbott & Merck are expected to come for plant inspection next month.
Dishman Pharma ended at Rs 222.65 down Rs 3.10 or 1.37 per cent on the NSE. It touched a high of Rs 230.25 and low of Rs 221.40 in today’s trade on volume of 3.78 lakh shares.
According to sources, the company officials met Abbott & Merck last week. Abbott & Merck are expected to come for plant inspection next month.
Dishman Pharma ended at Rs 222.65 down Rs 3.10 or 1.37 per cent on the NSE. It touched a high of Rs 230.25 and low of Rs 221.40 in today’s trade on volume of 3.78 lakh shares.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Market gains; Edelweiss, Dishman Pharma at fresh 52-week highADVERTISEMENT
